Fractyl Health, Inc. (GUTS)

$3.13

-0.15

(-4.57%)

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $3.07
    $3.46
    $3.13
    downward going graph

    1.92%

    Downside

    Day's Volatility :11.27%

    Upside

    9.54%

    downward going graph
  • $1.74
    $14.50
    $3.13
    downward going graph

    44.41%

    Downside

    52 Weeks Volatility :88.0%

    Upside

    78.41%

    downward going graph

Returns

PeriodFractyl Health, Inc.Index (Russel 2000)
3 Months
-49.19%
0.0%
6 Months
-65.6%
0.0%
1 Year
-75.64%
0.0%
3 Years
-75.64%
-22.3%

Highlights

Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
0.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Fractyl Health, Inc.(by analysts ranked 0 to 5 stars)

Technicals Summary

Sell

Neutral

Buy

Fractyl Health, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fractyl Health, Inc.
Fractyl Health, Inc.
61.34%
-65.6%
-75.64%
-75.64%
-75.64%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
5.97%
16.25%
37.11%
69.18%
305.56%
Novo Nordisk A/s
Novo Nordisk A/s
9.99%
-3.52%
34.24%
158.74%
417.73%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-5.15%
64.67%
22.72%
31.08%
198.44%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
0.45%
14.0%
36.06%
143.5%
167.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fractyl Health, Inc.
Fractyl Health, Inc.
NA
NA
NA
0.0
0.0
0.0
NA
NA
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
29.93
29.93
1.54
45.05
0.17
0.08
NA
261.41
Novo Nordisk A/s
Novo Nordisk A/s
44.01
44.01
1.98
3.44
0.89
0.23
0.01
25.24
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-2.55
-15.01
0.02
NA
-0.02
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
0.57
0.32
-0.03
0.13
NA
57.26
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fractyl Health, Inc.
Fractyl Health, Inc.
Buy
$171.6M
-75.64%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$124.7B
305.56%
29.93
32.04%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$585.3B
417.73%
44.01
34.84%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$32.3B
198.44%
NA
-3.11%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$120.9B
167.72%
32.84
-4.74%

Company Information

Organization
Fractyl Health, Inc.
Employees
112
CEO
Dr. Harith Rajagopalan M.D., Ph.D.
Industry
Miscellaneous

FAQs